When was Genalyte founded?

Genalyte was founded in 2007 and raised its 1st funding round 5 years after it was founded.

Where is Genalyte located?

Genalyte is headquartered in San Diego, United States. It is registered at San Diego, California.

How many employees does Genalyte have?

As of Jul 31, 2026, the latest employee count at Genalyte is 95.

Is Genalyte a funded company?

Genalyte is a funded company, having raised a total of $142M across 7 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Mar 30, 2012.

How much is Genalyte worth?

The latest valuation of Genalyte is $***** as of Nov 01, 2024.

When was the latest funding round of Genalyte?

Genalyte's latest funding was a $***** Series E round on Jan 11, 2021, with participation from 6 investors. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $5.46B in funding in 2026 to date.

Where does Genalyte rank among its competitors?

Genalyte ranks 3rd amongst 27 active competitors, of which 10 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Enumera Molecular, which secured $12.3M in Jul, 2026.

Who are the top competitors of Genalyte?

Genalyte's top competitors include PocDoc, Lucis and Lyfas. Among them, Enumera Molecular secured the most recent funding round in July, 2026.

Genalyte - 2026 Company Profile, Team, Funding & Competitors

Company Details

Real-time blood diagnostics at the point of care, revolutionizing lab testing with immediate results. They are redefining diagnostics, making lab testing accessible and immediate, eliminating delays and reducing errors. Their self-running device brings the power of a full-scale traditional lab into a single unit, designed to fit seamlessly into existing workflows. The cloud-based platform integrates directly with the EMR, enabling orders from the provider’s existing system and returning results instantly. They offer a comprehensive diagnostic menu, covering complete blood count, lipid panel, and comprehensive metabolic panel. This technology improves patient experience, reduces follow-up time, and eliminates pre-analytical errors. They cater to primary care, outpatient clinics, private practices, hospitals, surgery centers, government, and military facilities.

Website: www.genalyte.com/
Social
Registered Address: San Diego, California

Key Metrics

Founded Year

2007

Location

San Diego, United States

Stage

Series E

Total Funding

$142M in 7 rounds

Latest Funding Round

Series E, Jan 11, 2021, $*****

Post Money Valuation

$***** as on Nov 01, 2024

Investors

Khosla Ventures & 16 more

Ranked

3^rd among 27 active competitors

Employee Count

95 as on Jul 31, 2026

Investment & Acquisitions

BaseHealth

Similar Companies

PocDoc & 33 more

View Genalyte's full profile

Genalyte is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Genalyte, Inc. CIN: 208660027 , United States, Active	Dec 26, 999	-	37 (As on Dec 31, 2023)	-

Genalyte has raised a total funding of $142M over 7 rounds. Its first funding round was on Mar 30, 2012. Its latest funding round was a Series E round on Jan 11, 2021 for $*****. 6 investors participated in its latest round. Genalyte has 17 institutional investors.

Here is the list of recent funding rounds of Genalyte:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 11, 2021	8036584	Series E	9043322	1829622	3660625	6217059
Nov 21, 2016	2821874	Series D	2091716	4260295	7840422	9761696
Aug 18, 2015	6869444	Series C	2473498	5384828	Khosla Ventures	Redmile Group & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Genalyte's funding rounds and investors

The founders of Genalyte is Cary Gunn.

Here are the details of Genalyte's key team members:

Cary Gunn: Founder of Genalyte.

View details of Genalyte's Founder profiles and Board Members

Genalyte's employee count trend

Genalyte has 95 employees as of Jul 26. Here is Genalyte's employee count trend over the years:

Uncover Genalyte's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Genalyte include PocDoc, Lucis and Lyfas. Here is the list of Top 10 competitors of Genalyte, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PocDoc 2017, Cambridge (United Kingdom), Seed	Provider of smartphone based rapid testing for major diseases	$12.4M	MMC Ventures, Forward Partners & 4 others	54/100
2nd	Lucis 2023, Artannes-sur-indre (France), Series A	Provider of personalized health insights and recommendations based on blood tests	$29M	Singular, General Catalyst & 6 others	46/100
3rd	Genalyte 2007, San Diego (United States), Series E	Real-time blood diagnostics at the point of care	$142M	Redmile Group, Claremont Creek Ventures & 15 others	46/100
4th	Lyfas 2017, Bengaluru (India), Seed	Provider of AI-based predictive and preventive digital health test and home remedy	$2.26M	IIT Kanpur, Startup Basket & 20 others	38/100
5th	Adsys 2021, Jaipur (India), Seed	Provider of AI-based device for rapid blood diagnosis	$154K	Rainmatter, Social Alpha & 2 others	36/100
6th	The Smart Lollipop 2020, Barcelona (Spain), Seed	Disease diagnosis device for healthcare providers	$318K	Ship2B Ventures, Conector & 3 others	34/100
7th	Enumera Molecular 2022, Ann Arbor (United States), Series B	Developer of liquid biopsy tools	$31M	Arboretum Ventures	33/100
8th	OBI Medical 2002, Hadsund (Denmark), Seed	Provider of solutions for calculation of arterial acid-base and blood gas status	$3.23M	Vaekstfonden, Market Maturation Fund	29/100
9th	Smart Blood Analytics 2015, Chur (Switzerland), Unfunded	Provider of artificial intelligence based blood analyzing platform	-	-	28/100
10th	Biotasmart 2025, Valencia (United States), Seed	Provider of data-driven microbiota analysis and personalized nutrition recommendation platform	$592K	Angels Capital, Enisa & 5 others	27/100